John K. Scott Jr. - 31 Dec 2021 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Role
Director, 10%+ Owner
Signature
/s/ Erika L. Eves for John K. Scott, Jr. by power of attorney
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
4
Filing time
04 Jan 2022, 16:40:12 UTC
Previous filing
02 Dec 2021
Next filing
01 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +2,500 +0.03% $0.000000 8,083,395 31 Dec 2021 Direct F1, F2
holding NAVB Common Stock 10,139 31 Dec 2021 By spouse and children F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
F2 Issuance deferred at the request of the Reporting Person.
F3 Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed to have shared voting and/or dispositive power with respect to such shares.